Dear Mayo Clinic: My dad was diagnosed with hypertrophic cardiomyopathy at age 52. He has been on medication for a few months, but doctors said he likely will need surgery, even though his symptoms are very mild. Is surgery ...
May 6, 2016
0
21
EPFL researchers have discovered that the human brain suppresses the sensory effects of the heartbeat. They believe that this mechanism prevents internal sensations from interfering with the brain's perception of the external ...
May 4, 2016
4
788
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have demonstrated the crucial role of the NOTCH signaling pathway in the development of a fundamental heart structure, the heart valves. ...
Apr 29, 2016
0
2
A new generation of blood thinners can reduce the risk of stroke in patients with atrial fibrillation, without requiring frequent monitoring and dietary restrictions.
Apr 13, 2016
0
8
The Food and Drug Administration has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.
Apr 6, 2016
0
7
The death of a partner is linked to a heightened risk of developing an irregular heartbeat otherwise known as atrial fibrillation—itself a risk factor for stroke and heart failure—for up to a year afterwards, finds research ...
Apr 5, 2016
0
11
An estimated 1 in 68 children in the United States has autism. The neurodevelopmental disorder, which impairs communication and social interaction skills, can be treated with medications and behavioral therapies, though there ...
Feb 1, 2016
1
62
An irregular heartbeat (known as atrial fibrillation or AF) is a stronger risk factor for stroke, heart disease, heart failure and death in women than in men, although the cause is unclear, finds a study in The BMJ this week.
Jan 19, 2016
0
2
The U.S. Supreme Court refused on Tuesday to revive an Arkansas law that would have banned abortions after the 12th week of pregnancy if doctors can detect a fetal heartbeat.
Jan 19, 2016
0
3
(HealthDay)—Portrazza (necitumumab), in combination with two other chemotherapy drugs, has been approved by the U.S. Food and Drug Administration to treat advanced squamous non-small cell lung cancer, the agency said Tuesday ...
Nov 25, 2015
0
3
